Philip Toozs-Hobson

Philip Toozs-Hobson

Auto-generated profile, based on publicly available information

Philip Toozs-Hobson

Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, United Kingdom

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2007 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Closed access
PDF file
PLPm Latthe
Pm Latthe
RFR Foon
R Foon
PTP Toozs‐Hobson
P Toozs‐Hobson

1 September 2005 in European Urology
Verified
Journal Article
Closed access
CCC.R. Chapple
C.R. Chapple
RMR. Martinez-Garcia
R. Martinez-Garcia
LSL. Selvaggi
L. Selvaggi
PTP. Toozs-Hobson
P. Toozs-Hobson
WWW. Warnack
W. Warnack
JBJ. Bolodeoku
J. Bolodeoku

3 August 2016 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
LKLindsay M. Kindinger
Lindsay M. Kindinger
DMDavid A. MacIntyre
David A. MacIntyre
YLYun S. Lee
Yun S. Lee
JMJulian Marchesi
Julian Marchesi
ASAnn Smith
Ann Smith
PBPhillip R. Bennett
Phillip R. Bennett
Preterm birth, the leading cause of death in children under 5 years, may be caused by inflammation triggered by ascending vaginal infection. About 2 million cervical cerclages are performed annually to prevent preterm birth. The procedure is thought to provide structural support and maintain the endocervical mucus plug as a barrier to ascending infection. Two types of suture material are used for cerclage: monofilament or multifilament braided. Braided sutures are most frequently used, although no evidence exists to favor them over monofilament sutures. We assessed birth outcomes in a retrospective cohort of 678 women receiving cervical cerclage in five UK university hospitals and showed that braided cerclage was associated with increased intrauterine death (15% versus 5%; P = 0.0001) and preterm birth (28% versus 17%; P = 0.0006) compared to monofilament suture. To understand the potential underlying mechanism, we performed a prospective, longitudinal study of the vaginal microbiome in women at risk of preterm birth because of short cervical length (≤25 mm) who received braided (n = 25) or monofilament (n = 24) cerclage under comparable circumstances. Braided suture induced a persistent shift toward vaginal microbiome dysbiosis characterized by reduced Lactobacillus spp. and enrichment of pathobionts. Vaginal dysbiosis was associated with inflammatory cytokine and interstitial collagenase excretion into cervicovaginal fluid and premature cervical remodeling. Monofilament suture had comparatively minimal impact upon the vaginal microbiome and its interactions with the host. These data provide in vivo evidence that a dynamic shift of the human vaginal microbiome toward dysbiosis correlates with preterm birth.

12 December 2013 in Menopause International
Verified
Journal Article
Closed access
PDF file
DRDudley Robinson
Dudley Robinson
PTPhilip Toozs-Hobson
Philip Toozs-Hobson
LCLinda Cardozo
Linda Cardozo
The female genital and lower urinary tracts share a common embryological origin, arising from the urogenital sinus and both are sensitive to the effects of the female sex steroid hormones throughout life. Estrogen is known to have an important role in the function of the lower urinary tract and estrogen and progesterone receptors have been demonstrated in the vagina, urethra, bladder and pelvic floor musculature. In addition estrogen deficiency occurring following the menopause is known to cause atrophic change and may be associated with lower urinary tract symptoms such as frequency, urgency, nocturia, urgency incontinence and recurrent infection. These may also co-exist with symptoms of urogenital atrophy such as dyspareunia, itching, vaginal burning and dryness. Epidemiological studies have implicated estrogen deficiency in the aetiology of lower urinary tract symptoms with 70% of women relating the onset of urinary incontinence to their final menstrual period. Whilst for many years systemic and vaginal estrogen therapy was felt to be beneficial in the treatment of lower urinary and genital tract symptoms this evidence has recently been challenged by large epidemiological studies investigating the use of systemic hormone replacement therapy as primary and secondary prevention of cardiovascular disease and osteoporosis. The aim of this paper is to examine the effect of the sex hormones, estrogen and progesterone, on the lower urinary tract and to review the current evidence regarding the role of systemic and vaginal estrogens in the management of lower urinary tract symptoms and urogenital atrophy.

1 September 2012 in European Urology
Verified
Journal Article
Closed access
DTDouglas G. Tincello
Douglas G. Tincello
SKSara Kenyon
Sara Kenyon
KAKeith R. Abrams
Keith R. Abrams
CMChristopher Mayne
Christopher Mayne
PTPhilip Toozs-Hobson
Philip Toozs-Hobson
MSMark Slack
Mark Slack

27 November 2012 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
PDF file
CGC Glazener
C Glazener
AEAndrew Elders
Andrew Elders
CMC MacArthur
C MacArthur
RLRj Lancashire
Rj Lancashire
PHP Herbison
P Herbison
FGfor the ProLong Study Group
for the ProLong Study Group
Objectives: To investigate prolapse symptoms and objectively measured pelvic organ prolapse, 12 years after childbirth, and association with delivery mode history.Design: Twelve‐year longitudinal study.Setting: Maternity units in Aberdeen, Birmingham and Dunedin.Population: Women dwelling in the community.Methods: Data from women were collected 12 years after an index birth and women were invited for examination. Logistic regression investigated associations between risk factors and prolapse symptoms and signs.Main outcome measures: Prolapse symptom score (POP‐SS); objectively measured prolapse (POP‐Q).Results: Of 7725 continuing women, 3763 (49%) returned questionnaires at 12 years. The median POP‐SS score was 2 (IQR 0–4). One or more forceps deliveries (OR 1.20, 95% CI 1.04–1.38) and a body mass index (BMI) over 25 were associated with higher (worse) POP‐SS scores, but age over 25 years at first delivery was associated with lower (better) scores. There was no protective effect if all deliveries were by caesarean section (OR 0.84, 95% CI 0.69–1.02). Objective prolapse was found in 182/762 (24%) women. Women aged over 30 years when having their first baby and parity were significantly associated with prolapse. Compared with women whose births were all spontaneous vaginal deliveries, women who had all births by caesarean section were the least likely to have prolapse (OR 0.11, 95% CI 0.03–0.38), and there was a reduced risk after forceps or a mixture of spontaneous vaginal delivery and caesarean section.Conclusions: These findings are at odds with each other, suggesting that prolapse symptoms and objective prolapse may not be in concordance, or are associated with different antecedent factors. Further follow‐up is planned.